Quote | AbCellera Biologics Inc. (NASDAQ:ABCL)
Last: | $3.65 |
---|---|
Change Percent: | -6.41% |
Open: | $3.86 |
Close: | $3.90 |
High: | $3.8799 |
Low: | $3.65 |
Volume: | 848,915 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
News | AbCellera Biologics Inc. (NASDAQ:ABCL)
Data show how AbCellera is expanding the reach of T-cell engagers with: CD3-binding antibodies that consistently generate T-cell engagers with potent tumor-cell killing and low cytokine release across multiple tumor targets, including PSMA, B7-H4, and 5T4 Costimulatory CD28-bind...
AbCellera (Nasdaq: ABCL) will announce its first quarter 2024 financial results on Tuesday, May 7, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day. A live audio webcast of the earnings conference may be accessed through a link that ...
Message Board Posts | AbCellera Biologics Inc. (NASDAQ:ABCL)
Subject | By | Source | When |
---|---|---|---|
Price gaining last up | the_stockoracle | investorshub | 04/29/2023 10:05:27 AM |
$ABCL Good read | StockRoomBully | investorshub | 04/28/2023 4:12:38 PM |
$ABCL Price now last up | crudeoil24 | investorshub | 04/27/2023 12:55:58 PM |
bulls and bears | Marvy | investorshub | 04/24/2023 3:06:20 PM |
$THER MEME STOCK TO BUY NOW | Jayzp | investorshub | 04/24/2023 12:35:50 PM |
News, Short Squeeze, Breakout and More Instantly...
AbCellera Biologics Inc. Company Name:
ABCL Stock Symbol:
NASDAQ Market:
Data show how AbCellera is expanding the reach of T-cell engagers with: CD3-binding antibodies that consistently generate T-cell engagers with potent tumor-cell killing and low cytokine release across multiple tumor targets, including PSMA, B7-H4, and 5T4 Costimulatory CD28-bind...
AbCellera (Nasdaq: ABCL) will announce its first quarter 2024 financial results on Tuesday, May 7, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day. A live audio webcast of the earnings conference may be accessed through a link that ...
AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the Bloom Burton Healthcare Conference on Tuesday, April 16, 2024, at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time). A live audio webcast of the presentation may be accessed through a link that will...